🇺🇸 FDA
Patent

US 10286050

Multi-epitope TARP peptide vaccine and uses thereof

granted A61KA61K2039/572A61K2039/575

Quick answer

US patent 10286050 (Multi-epitope TARP peptide vaccine and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/572, A61K2039/575, A61K2039/70, A61K2239/58